secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-01-23T23:59:59+00:00
Accession:  0001829126-26-000502
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO receives Nasdaq bid price deficiency notice; 180-day compliance period until July 20, 2026
--------------------------------------------------------------------------------

- Letter dated Jan 20, 2026; closing bid price below $1.00 for 30 consecutive business days (Dec 3, 2025–Jan 16, 2026).
- Must maintain closing bid price ≥$1.00 for at least ten consecutive business days during the compliance period to regain compliance.
- If not cured by July 20, 2026, may be eligible for an additional 180-day period if other Nasdaq listing standards are met.
- No immediate impact on stock listing; shares continue trading on Nasdaq subject to other requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626000502/0001829126-26-000502-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626000502/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-000502

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer